MECP2 mutation database launched to study Rett syndrome:
This article was originally published in Clinica
Researchers at Edinburgh University yesterday (October 2 2003) launched an interactive database to study Rett syndrome. This neurological disorder affects mainly girls, occurring once in every 10-15,000 female births, making it the second most common cause of mental retardation after Down's syndrome. It is commonly associated with a mutation in the MECP2 gene. The project (www.MeCP2.org.uk) led by Dr Brian Hendrich and Dr Skirmantas Kriaucionis aims to help understand how certain symptoms correlate with different mutations and how symptoms change over time.
You may also be interested in...
GNC hires Josh Burris as chief US officer; Clasado BioSciences adds Bellchambers as commercial director; and Barentz plans expansion with Cinven investment.
The House passage of a Democratic bill authorizing the federal government to negotiate drug prices in Medicare has sharpened the debate over how prices feed innovation, but the underlying policy stands little chance of being enacted without a Democratic wave in the next election. Pink Sheet's table highlights the key provisions of HR 3 and other pending pricing legislation.